Literature DB >> 22847008

Role of p63 in Development, Tumorigenesis and Cancer Progression.

Johann Bergholz1, Zhi-Xiong Xiao.   

Abstract

The p53-related protein p63 has pleiotropic functions, including cell proliferation, survival, apoptosis, differentiation, senescence, and aging. The p63 gene is expressed as multiple isoforms that either contain an N-terminal p53-homologous transactivation domain (TAp63) or that lack this domain (ΔNp63). Multiple studies have demonstrated that p63 plays a crucial role in stratified epithelial development, and have shown the importance of p63 for maintaining proliferation potential, inducing differentiation, and preventing senescence. Additionally, much research focuses on the role of p63 in cancer progression. Clinical evidence suggests that p63 may play a role in inhibiting metastasis. Similarly, genetic mice models together with cell culture data strongly indicate that p63 deficiency may be a causative factor for metastatic spread. Moreover, the role of p63 in cancer metastasis has been shown to be greatly related to the ability of mutant p53 to promote cancer malignancy. However, there is still much confusion as to what the role of each specific isoform is. In this review, we highlight some of the major findings in the current literature regarding the role of specific p63 isoforms in development, tumorigenesis, and particularly in cancer metastasis.

Entities:  

Year:  2012        PMID: 22847008      PMCID: PMC3460051          DOI: 10.1007/s12307-012-0116-9

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  111 in total

1.  RACK1 and stratifin target DeltaNp63alpha for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage.

Authors:  Alexey Fomenkov; Rachel Zangen; Yi-Ping Huang; Motonobu Osada; Zhongmin Guo; Tanya Fomenkov; Barry Trink; David Sidransky; Edward A Ratovitski
Journal:  Cell Cycle       Date:  2004-10-06       Impact factor: 4.534

2.  Perp is a p63-regulated gene essential for epithelial integrity.

Authors:  Rebecca A Ihrie; Michelle R Marques; Bichchau T Nguyen; Jennifer S Horner; Cristian Papazoglu; Roderick T Bronson; Alea A Mills; Laura D Attardi
Journal:  Cell       Date:  2005-03-25       Impact factor: 41.582

3.  Structural evolution of p53, p63, and p73: implication for heterotetramer formation.

Authors:  Andreas C Joerger; Sridharan Rajagopalan; Eviatar Natan; Dmitry B Veprintsev; Carol V Robinson; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

4.  Expression of the p53 homologue p63 in early cervical neoplasia.

Authors:  B J Quade; A Yang; Y Wang; D Sun; J Park; E E Sheets; A Cviko; J M Federschneider; R Peters; F D McKeon; C P Crum
Journal:  Gynecol Oncol       Date:  2001-01       Impact factor: 5.482

5.  p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.

Authors:  M Dohn; S Zhang; X Chen
Journal:  Oncogene       Date:  2001-05-31       Impact factor: 9.867

6.  Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma.

Authors:  Matthew R Ramsey; Lei He; Nicole Forster; Benjamin Ory; Leif W Ellisen
Journal:  Cancer Res       Date:  2011-04-28       Impact factor: 12.701

7.  The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms.

Authors:  Isabella Manni; Simona Artuso; Silvia Careccia; Maria Giulia Rizzo; Renato Baserga; Giulia Piaggio; Ada Sacchi
Journal:  FASEB J       Date:  2009-07-16       Impact factor: 5.191

8.  p63 expression in normal, hyperplastic and malignant breast tissues.

Authors:  Xiaojuan Wang; Ichiro Mori; Weihua Tang; Misa Nakamura; Yasushi Nakamura; Misako Sato; Takeo Sakurai; Kennichi Kakudo
Journal:  Breast Cancer       Date:  2002       Impact factor: 4.239

9.  TAp73 knockout shows genomic instability with infertility and tumor suppressor functions.

Authors:  Richard Tomasini; Katsuya Tsuchihara; Margareta Wilhelm; Masashi Fujitani; Alessandro Rufini; Carol C Cheung; Fatima Khan; Annick Itie-Youten; Andrew Wakeham; Ming-Sound Tsao; Juan L Iovanna; Jeremy Squire; Igor Jurisica; David Kaplan; Gerry Melino; Andrea Jurisicova; Tak W Mak
Journal:  Genes Dev       Date:  2008-09-19       Impact factor: 11.361

10.  The E3 ubiquitin ligase Itch controls the protein stability of p63.

Authors:  Mario Rossi; Rami I Aqeilan; Michael Neale; Eleonora Candi; Paolo Salomoni; Richard A Knight; Carlo M Croce; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

View more
  42 in total

1.  Metformin Promotes AMP-activated Protein Kinase-independent Suppression of ΔNp63α Protein Expression and Inhibits Cancer Cell Viability.

Authors:  Yong Yi; Deshi Chen; Juan Ao; Shengnan Sun; Min Wu; Xiaorong Li; Johann Bergholz; Yujun Zhang; Zhi-Xiong Xiao
Journal:  J Biol Chem       Date:  2017-02-13       Impact factor: 5.157

Review 2.  Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.

Authors:  Yasushi Sasaki; Miyuki Tamura; Ryota Koyama; Takafumi Nakagaki; Yasushi Adachi; Takashi Tokino
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

3.  The Value of a Novel Panel of Cervical Cancer Biomarkers for Triage of HPV Positive Patients and for Detecting Disease Progression.

Authors:  Norbert Varga; Johanna Mózes; Helen Keegan; Christine White; Lynne Kelly; Loretto Pilkington; Márta Benczik; Schaff Zsuzsanna; Gábor Sobel; Róbert Koiss; Edit Babarczi; Miklos Nyíri; Laura Kovács; Sebe Attila; Borbála Kaltenecker; Adrienn Géresi; Adrienn Kocsis; John O'Leary; Cara M Martin; Csaba Jeney
Journal:  Pathol Oncol Res       Date:  2016-08-06       Impact factor: 3.201

4.  p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis.

Authors:  A R Yallowitz; E M Alexandrova; F Talos; S Xu; N D Marchenko; U M Moll
Journal:  Cell Death Differ       Date:  2014-01-17       Impact factor: 15.828

5.  TIP60 up-regulates ΔNp63α to promote cellular proliferation.

Authors:  Andrew J Stacy; Jin Zhang; Michael P Craig; Akshay Hira; Nikhil Dole; Madhavi P Kadakia
Journal:  J Biol Chem       Date:  2019-10-10       Impact factor: 5.157

6.  ATRAID regulates the action of nitrogen-containing bisphosphonates on bone.

Authors:  Lauren E Surface; Damon T Burrow; Jinmei Li; Jiwoong Park; Sandeep Kumar; Cheng Lyu; Niki Song; Zhou Yu; Abbhirami Rajagopal; Yangjin Bae; Brendan H Lee; Steven Mumm; Charles C Gu; Jonathan C Baker; Mahshid Mohseni; Melissa Sum; Margaret Huskey; Shenghui Duan; Vinieth N Bijanki; Roberto Civitelli; Michael J Gardner; Chris M McAndrew; William M Ricci; Christina A Gurnett; Kathryn Diemer; Fei Wan; Christina L Costantino; Kristen M Shannon; Noopur Raje; Thomas B Dodson; Daniel A Haber; Jan E Carette; Malini Varadarajan; Thijn R Brummelkamp; Kivanc Birsoy; David M Sabatini; Gabe Haller; Timothy R Peterson
Journal:  Sci Transl Med       Date:  2020-05-20       Impact factor: 17.956

7.  ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis.

Authors:  Linshan Hu; Shan Liang; Hu Chen; Tao Lv; Junfeng Wu; Deshi Chen; Min Wu; Shengnan Sun; Haibo Zhang; Han You; Hongbin Ji; Yujun Zhang; Johann Bergholz; Zhi-Xiong Jim Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-03       Impact factor: 11.205

8.  Distinct function of P63 isoforms during embryonic skeletal development.

Authors:  Yaojuan Lu; Sam Abbassi; Feifei Li; Ming Ding; Guojun Wu; Junxia Gu; Qiping Zheng
Journal:  Gene       Date:  2013-02-26       Impact factor: 3.688

Review 9.  p63-related signaling at a glance.

Authors:  Matthew L Fisher; Seamus Balinth; Alea A Mills
Journal:  J Cell Sci       Date:  2020-09-11       Impact factor: 5.285

10.  Functions of TAp63 and p53 in restraining the development of metastatic cancer.

Authors:  E H Tan; J P Morton; P Timpson; P Tucci; G Melino; E R Flores; O J Sansom; K H Vousden; P A J Muller
Journal:  Oncogene       Date:  2013-07-22       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.